BWAY
Price
$15.85
Change
-$0.12 (-0.75%)
Updated
Sep 5 closing price
Capitalization
295.36M
67 days until earnings call
DXR
Price
$11.06
Change
-$0.27 (-2.38%)
Updated
Sep 5 closing price
Capitalization
55.13M
Interact to see
Advertisement

BWAY vs DXR

Header iconBWAY vs DXR Comparison
Open Charts BWAY vs DXRBanner chart's image
BrainsWay
Price$15.85
Change-$0.12 (-0.75%)
Volume$47.66K
Capitalization295.36M
Daxor
Price$11.06
Change-$0.27 (-2.38%)
Volume$12.86K
Capitalization55.13M
BWAY vs DXR Comparison Chart in %
Loading...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BWAY vs. DXR commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Buy and DXR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BWAY: $15.85 vs. DXR: $11.06)
Brand notoriety: BWAY and DXR are both not notable
BWAY represents the Medical/Nursing Services, while DXR is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BWAY: 73% vs. DXR: 34%
Market capitalization -- BWAY: $295.36M vs. DXR: $55.13M
BWAY [@Medical/Nursing Services] is valued at $295.36M. DXR’s [@Pharmaceuticals: Other] market capitalization is $55.13M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.68B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 0 FA rating(s) are green whileDXR’s FA Score has 1 green FA rating(s).

  • BWAY’s FA Score: 0 green, 5 red.
  • DXR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BWAY and DXR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 6 TA indicator(s) are bullish while DXR’s TA Score has 3 bullish TA indicator(s).

  • BWAY’s TA Score: 6 bullish, 4 bearish.
  • DXR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BWAY is a better buy in the short-term than DXR.

Price Growth

BWAY (@Medical/Nursing Services) experienced а +1.86% price change this week, while DXR (@Pharmaceuticals: Other) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

BWAY is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BWAY($295M) has a higher market cap than DXR($55.1M). DXR has higher P/E ratio than BWAY: DXR (69.13) vs BWAY (57.04). BWAY YTD gains are higher at: 68.081 vs. DXR (43.823). DXR has less debt than BWAY: DXR (730K) vs BWAY (6.13M). BWAY has higher revenues than DXR: BWAY (46.1M) vs DXR (2.13M).
BWAYDXRBWAY / DXR
Capitalization295M55.1M535%
EBITDA8.3MN/A-
Gain YTD68.08143.823155%
P/E Ratio57.0469.1383%
Revenue46.1M2.13M2,163%
Total Cash78MN/A-
Total Debt6.13M730K840%
FUNDAMENTALS RATINGS
BWAY vs DXR: Fundamental Ratings
BWAY
DXR
OUTLOOK RATING
1..100
2593
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
7190
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BWAY's Valuation (77) in the Medical Specialties industry is in the same range as DXR (90). This means that BWAY’s stock grew similarly to DXR’s over the last 12 months.

BWAY's Profit vs Risk Rating (46) in the Medical Specialties industry is somewhat better than the same rating for DXR (100). This means that BWAY’s stock grew somewhat faster than DXR’s over the last 12 months.

BWAY's SMR Rating (71) in the Medical Specialties industry is in the same range as DXR (90). This means that BWAY’s stock grew similarly to DXR’s over the last 12 months.

BWAY's Price Growth Rating (36) in the Medical Specialties industry is in the same range as DXR (41). This means that BWAY’s stock grew similarly to DXR’s over the last 12 months.

DXR's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for BWAY (100). This means that DXR’s stock grew significantly faster than BWAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYDXR
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 29 days ago
79%
Bearish Trend 4 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
69%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARZGF39.62N/A
N/A
Assicurazioni Generali Spa
MGYOY4.40N/A
N/A
MOL Magyar Olaj-Es Gazipari RT
GBMCF0.12N/A
N/A
Green Bridge Metals Corporation
MIZUF17.35N/A
N/A
Mizuno Corp.
LVPA1.01N/A
N/A
Lvpai Group Limited

BWAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with STIM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then STIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-0.75%
STIM - BWAY
34%
Loosely correlated
-2.42%
CLPT - BWAY
34%
Loosely correlated
-0.27%
BFLY - BWAY
32%
Poorly correlated
+1.96%
ISRG - BWAY
31%
Poorly correlated
+2.71%
ARAY - BWAY
31%
Poorly correlated
N/A
More

DXR and

Correlation & Price change

A.I.dvisor tells us that DXR and IART have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DXR and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXR
1D Price
Change %
DXR100%
-2.38%
IART - DXR
33%
Poorly correlated
+2.17%
BWAY - DXR
27%
Poorly correlated
-0.75%
NOTV - DXR
24%
Poorly correlated
+2.50%
QIPT - DXR
23%
Poorly correlated
-0.38%
COO - DXR
20%
Poorly correlated
+0.13%
More